MedPath

Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer

Phase 3
Conditions
Surgery: Axillary Dissection
Breastcancer
Registration Number
NCT02967146
Lead Sponsor
Samsung Medical Center
Brief Summary

Anti-adhesive effect and Safety of a mixed solid of poloxamer, gelatin and chitosan(Mediclore®) after axillary dissection for breast cancer

Detailed Description

A Multicenter Double-blinded, Randomized Study

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
170
Inclusion Criteria
  • the patients needed axillary dissection in breast cancer
  • Written informed consent
  • Patients without clinically significant lab
  • the patients who are diagnosed 'positive for metastasis' by sentinel lymph node biopsy
Exclusion Criteria
  • having enrolled another clinical trials within 1 month
  • Immunosuppression or autoimmune disease
  • Anticoagulant, general steroids within a week from surgery
  • Incompatible medications
  • Serious diseases (heart failure, renal failure, liver failure, uncontrolled hypertension, diabetes mellitus, coagulation deficiencies)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
sum of ROM(range of motion)4weeks

to compare the differences of sum of ROM between two groups comparision of the differences of sum of ROM between two groups ROM: forward flexion and horizontal abduction

Secondary Outcome Measures
NameTimeMethod
pain assessment (numeric pain rating scale)4weeks, 24weeks

to compare the differences of the pain related with motions of upper limbs

sum of ROM(range of motion)24weeks

comparision of the differences of sum of ROM between two groups ROM: forward flexion and horizontal abduction

Scoring DASH(Disablities of the arm, shoulder and hand)4weeks, 24weeks

to compare the differences of the DASH score

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul City, Korea, Republic of

Samsung Medical Center
🇰🇷Seoul City, Korea, Republic of
Sung Min Park, MD
Contact
+82-2-3410-3660
gs_sm.park@samsung.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.